Skip to main content
. 2018 Oct 4;11(5):405–415. doi: 10.1159/000492943

Fig. 2.

Fig. 2

Gut microbiota in a healthy individual and in an allo-HSCT patient. Cancer conditioning treatment and supporting therapy with antibiotics or antifungal agents disrupt the microbiota and its functions (left panel) resulting in a range of side effects (right panel) that lead to GvHD causing significant mortality in allo-HSCT patients.